A61K 51 - Preparations containing radioactive substances for use in therapy or testing in vivo

Patents for A61K 51 - Preparations containing radioactive substances for use in therapy or testing in vivo (24,291)
12/2009
12/23/2009	WO2009035959A3 Radiofluorination methods
12/23/2009	EP2135623A1 Method of treatment of a BCL-2 disorder using BCL-2 antisense oligomers
12/23/2009	EP2134401A2 Guidance and implantation of catheters
12/23/2009	EP1483297B1 Antibodies derived from anti ed-b l19 and targeting tumor vasculature
12/23/2009	EP1274861B1 Compositions and methods for identifying and targeting cancer cells
12/23/2009	CN101607913A 改进的螯合剂缀合物 Improved chelator conjugate
12/23/2009	CN100571787C Para-hydrogen labelled agents and their use in magnetic resonance imaging
12/23/2009	CA2725934A1 Novel substituted indoles
12/22/2009	US7635464 Selective targeting of apoptotic cells
12/22/2009	US7635463 Carrier with a metal binding domain, a metal ion, and an active agent; e.g., polylysine with a polyoxyethylene side chain with a polyalkylenepolyaminepolyacetic acid bonded to a transition metal ion bonded to a protein or nucleotide; drug delivery
12/22/2009	CA2426210C Treatment of pcp addiction and pcp addiction-related behavior
12/22/2009	CA2133833C Method and kit for imaging and treating organs and tissues
12/17/2009	WO2009152445A1 Imaging of atherosclerotic plaques using liposomal imaging agents
12/17/2009	WO2009152440A1 Small molecule ligand-drug conjugates for targeted cancer therapy
12/17/2009	WO2009152222A2 Fluid bed meal containing a marker and methods of making
12/17/2009	WO2009151646A2 Non-invasive diagnostic agents and methods of diagnosing infectious disease
12/17/2009	WO2009150139A2 Indolyl-pyridazinyl-diazabicyclononane derivatives in labelled and unlabelled form and their use in diagnostic methods
12/17/2009	WO2009130517A3 Method and compound for tracking micrometastases of prostate androgen receptors
12/17/2009	WO2009053644A8 Use of lanthanide-based nanoparticles as radiosensitizing agents
12/17/2009	WO2008144931A8 Compositions and methods for modulating gated ion channels
12/17/2009	US20090311413 Method and device for radiotherapy
12/17/2009	US20090311179 Selective Targeting of Apoptotic Cells
12/17/2009	US20090311178 Pyrrolinidium derivatives as m3 muscarinic receptors
12/17/2009	US20090311177 Radiolabelling Methods
12/17/2009	US20090311176 2-Arylpyrazolo[L,5-Alpha] Pyrimidin-3-YL Acetamide Derivatives as Ligands for Translocator Protein (18 Kda)
12/17/2009	US20090311175 Methods for treating thyroid cancer
12/17/2009	US20090311174 Method For Treating Cancer
12/17/2009	US20090311173 Method and device for radiotherapy
12/17/2009	US20090311172 Massage cream and massaging method using the same
12/17/2009	CA2727447A1 Fluid bed meal containing a marker and methods of making
12/16/2009	EP2131867A2 Modified hydroxypolymer conjugates with killing effect on tumor cells
12/16/2009	CN100569748C Method for purifying 18F-Fallypride marker precursor compound
12/15/2009	US7632927 comprises an alpha-emitter (e.g. Bi-213) bound to the monoclonal antibody C595 by a chelating agent selected from DOTA, cDTPA, DTPA-CHX-A or TETA; anticarcinogenic agent particularly efficient for treatment of pancreatic and prostate cancer, as well as for breast and ovarian cancer
12/15/2009	US7632485 Catalytic radiofluorination
12/15/2009	US7632484 Ethylenedicysteine (EC)-drug conjugates, compositions and methods for tissue specific disease imaging
12/15/2009	CA2333125C Alpha emitting constructs and uses thereof
12/10/2009	WO2009148554A1 Achievement of high therapeutic index through molecular imaging guided targeted drug treatment
12/10/2009	WO2009148121A1 Novel molecular assembly, molecular probe for molecular imaging and molecular probe for drug delivery system using the same, and molecular imaging system and drug delivery system
12/10/2009	WO2009128045A3 Apparatus and method for preparing medicines containing radioactive substances
12/10/2009	WO2009112488A3 Polyether polyol dendron conjugates with effector molecules for biological targeting
12/10/2009	WO2009106566A3 Therapy selection method
12/10/2009	US20090304592 Treatment of metastatic tumors
12/10/2009	US20090304587 Biodegradable composite for internal local radiotherapy
12/10/2009	US20090304586 Chelating Agent Conjugated Alpha-MSH Peptide Derivatives, Preparation Method Thereof and Composition for Diagnosis and Treatment of Melanoma Comprising the Same as an Active Ingredient
12/10/2009	US20090304585 Stabilized Compositions and Methods for Radiolabeling Pharmaceuticals with Alpha-Particle Emitters
12/10/2009	US20090304584 Conjugates comprising a gaba- or glycine compound, pharmaceutical compositions and combinations thereof and their use in treating cns disorders
12/10/2009	US20090304583 Pathological tissue detection and treatment employing targeted benzoindole optical agents
12/10/2009	US20090304582 Imaging Protocols
12/10/2009	US20090304581 Single wall nanotube constructs and uses therefor
12/10/2009	US20090304580 Anti-Pancreatic Cancer Antibodies
12/10/2009	US20090304579 Cancerous Disease Modifying Antibodies
12/10/2009	US20090304578 Cancerous Disease Modifying Antibodies
12/10/2009	US20090304577 Peptides for Treatment and Diagnosis of Autoimmune Disease
12/10/2009	US20090304576 Device for delivery of anti-cancer agents to tissue
12/10/2009	US20090304575 In vitro method for identifying compounds for cancer therapy
12/09/2009	EP1689425B1 Pharmaceutical formulations for the sustained release of one or more active principles and therapeutic applications thereof
12/09/2009	CN101597323A Radioactive isotope labeling polypeptide for tumor imaging
12/09/2009	CN101597228A C-acetate preparation method
12/08/2009	US7628983 treating edema with Kallikrein inhibitor; bovine pancreatic trypsin inhibitor mutants; possibly ecallantide
12/08/2009	US7628975 Compositions and methods for detecting and quantifying COX-2 activity and 2-arachidonylgycerol metabolites
12/08/2009	CA2347424C Use of dextran covalently bound to charged groups for selective targeting of tumor by local, intratumoral or intracavitary administration
12/03/2009	WO2009143985A1 New molecule 5-hydroxy-l-(4-hydroxy-3-[124i]iodo-5-methoxyphenyl)-7- (4-hydroxy-3-methoxyphenyl)-l,4,6-heptatrien-3-one for pet investigations and radiotherapy.
12/03/2009	WO2009094741A8 Radiopharmaceuticaldrug and pharmaceutical composition for treatment and diagnosis of cancer
12/03/2009	US20090297447 Synthesis and evaluation of 18f-labelled-alkyl-1-[(1r)-1-phenylethyl]-1h-imidazole-5-carboxylate as a tracer for the quantification of beta-11-hydroxylase enzyme in the adrenal glands
12/03/2009	US20090297446 Labeled iodinated tropane formulation
12/03/2009	US20090297445 Method for the use of [11c] carbon monoxide in labeling synthesis of 11c-labelled amides using metal amides and phot-induced free radical carbonylation
12/03/2009	US20090297444 Peptide analogs of alpha-melanocyte stimulating hormone
12/03/2009	US20090297443 Labeled ALPHA4BETA2 Ligands and Methods Therefor
12/03/2009	US20090297442 Radiopharmaceutical products
12/03/2009	US20090297441 Imaging Agents
12/03/2009	US20090297440 Gene Differentially Expressed in Breast and Bladder Cancer and Encoded Polypeptides
12/03/2009	US20090297439 Anti-met monoclonal antibody, fragments and derivatives thereof for use in tumor diagnosis, corresponding compositions and kits
12/03/2009	US20090297438 Human Monoclonal Antibodies to Prostate Specific Membrane Antigen (PSMA)
12/03/2009	US20090297437 Radioactive device
12/03/2009	US20090297436 Antibodies to il-6 and use thereof
12/03/2009	DE102008024309A1 New tetrahydro-pyran compounds useful to prepare 2-desoxy-2-(F-18)fluoroglucosyl-1-azide, which is useful for F-18-glycosylation of bioactive alkynyl or ethinyl derivatized molecule to form conjugated tetrahydro-pyran biomolecule
12/02/2009	EP2128140A1 Method for producing 2-nitroimidazole derivative
12/02/2009	EP2128135A1 Method for synthesis of nitroxyl radical
12/02/2009	EP2128130A1 Process for production of precursor compound for radioactive halogen-labeled organic compound
12/02/2009	EP2128124A1 Novel hexatriene- -carbonyl compound
12/02/2009	EP2127683A1 Anti-Met monoclonal antibody, fragments and derivatives thereof for use in tumor imaging, corresponding compositions and kits
12/02/2009	EP2126055A1 Cancer disease modifying antibody 010207-01 produced by hybridoma cell line ar51a630.3.
12/02/2009	EP2125620A2 Production of thorium 228 starting from a natural thorium salt
12/02/2009	EP2125039A2 Synthesis of a radiofluorinated peptide using photolabile protecting groups
12/02/2009	EP1534347B1 Conjugates of n-hydroxypropymethacrylamide-methacrylate copolymer with nuclide activation agent and/or anti-cancer compounds
12/02/2009	CN101595213A Cancerous disease modifying antibodies
12/02/2009	CN101595083A [F-18]-labeled l-glutamic acid, [F-18]-labeled l-glutamine, derivatives thereof and use thereof and processes for their preparation
12/02/2009	CN101594886A Radioimaging moieties coupled to peptidase-binding moieties for imaging tissues and organs that express peptidases
12/02/2009	CN101594883A Diagnosis and treatment of cancer using anti-EREG antibody
12/02/2009	CN100563812C Chemical synthesizer capable of preparing multiple fluoro-marking agent
12/02/2009	CN100563718C Gas-filled microvesicle assembly for contrast imaging
12/01/2009	US7625865 Insulin highly respirable microparticles
12/01/2009	US7625862 Method for making a high oxygen affinity modified hemoglobin for oxygen transport
12/01/2009	US7625558 Anticancer agents; administering nucleic acid which dimerizes with protein
11/2009
11/29/2009	CA2665957A1 Anti-met monoclonal antibody, fragments and derivatives thereof for use in tumor diagnosis, corresponding compositions and kits
11/26/2009	WO2009143101A2 Gastrin releasing peptide compounds
11/26/2009	WO2009143023A2 Neoplasia targeting peptides and methods of using the same
11/26/2009	WO2009141137A2 New molecule [124i][2-(3'-iodo-4'-methylaminophenyl)-6-hydroxy-benzothialzole] for pet investigations and radiotherapy
11/26/2009	WO2009141091A1 Novel [f-18] -labelled l-glutamic acid- and l-glutamine derivatives (i), use thereof and method for their production
11/26/2009	WO2009141090A1 {f-19} -labeled l-glutamic acid and l-glutamine derivative (iii), use thereof and method for obtaining them

1 ... 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 ... 243